tirzepatide and osteoporosis GLP-1 weight loss drug study finds small increase in risk of gout Effects of Semaglutide and Tirzepatide

Historically, women have reached target values for modifiable CV risk factors, including HbA 1c , systolic and diastolic blood pressure, and lipid levels, less frequently than men [31,32,33]

Individual responses vary widely based on pre-existing conditions, dose, diet, and lifestyle factors

Taking your injection the same day each week, without skipping doses, typically works better than being inconsistent with timing

Image Credit: Love Employee / Shutterstock In a recent study published in the journal Communications Medicine , a group of researchers examined associations between initiation of tirzepatide or semaglutide and incident neuropsychiatric diagnoses in adults with obesity, compared with other weight-loss treatments, with separate analyses for individuals with and without type 2 diabetes

On August 28, PSM Executive Director Shabbir Safdar presented a webinar about the threats of counterfeit GLP-1s for the National Association of Boards of Pharmacy